Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-10-16

FDA Approved: RASAGILINE — Supplemental Application (Alvogen, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Rasagiline by Alvogen, Inc., resulting in an approved supplemental application for the generic drug Rasagiline.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RASAGILINE (rasagiline)

Snippet

SUPPL AP for RASAGILINE (RASAGILINE)